EORTC - European Journal of Cancer (EJC)

The European Journal of Cancer (EJC) is a truly multidisciplinary publication that seeks to publish papers of interest to the entire community involved in cancer research and its management. 2010 has been the busiest year on record for EJC with more than 2000 manuscripts submitted, and, given the high quality of many of these submissions, it is a challenge for the editors that they can only accept approximately 20%, but this in turn reflects on the quality of the journal. The editorial and publishing times continue to be extremely competitive with submission to a reviewer invitation averaging less than nine days and indeed submission to an editorial decision in 18 days - even for disappointed authors a clear decision within three weeks of submission is helpful! In 2010 we published Volume 46 which included 18 issues, where all accepted articles appeared as Articles in Press, on-line on Science Direct within six weeks of acceptance. At this stage articles are also made available on Pubmed increasing their visibility within the community. All articles were published in print within five months of acceptance in 2010. Our readership is now largely on-line, and there are approximately one million articles downloaded from Science Direct per year. The geographical distribution of usage is illustrated in the table below, showing as expected predominance from Western Europe but a significant readership from North America and Asia.

 

Geographical Distribution of Online Usage 2009

 

Analysis of the most popular articles either by downloads or those highly cited reveal a clear spread across the different disciplines of clinical research, translational research, epidemiology, and basic science. Two Special Issues published in 2010 have attracted particular interest; 46 (7) entitled“Stopping cancer in its tracks: Metastasis as a therapeutic target” was edited by P S Steeg and J Sleeman. The reviews highlight cancer metastasis as a target for new therapies emphasizing the progress in translating basic scientific knowledge to practical clinical managements. The second Special Issue published, 46 (14) entitled “Implementing cancer prevention in Europe” was edited by Jan Willem Coebergh and colleagues and highlights the fact that although mortality from cancer is decreasing in the European Union, it’s incidence is continuing to increase. The current economic crisis threatens to affect cancer incidence in many ways and cancer prevention strategies will become ever more important. This issue places special emphasis on the need to strengthen cancer prevention using a holistic and global approach, focusing on the biggest risk factors of smoking, obesity, alcohol and physical inactivity.

EJC is the official journal of the EORTC, ECCO, EACR and EUSOMA.

The editors of EJC are most grateful for the contribution in particular from members of EORTC both for the submission of original research and for their help in reviewing the very many papers submitted.

All correspondence and manuscript submission should be addressed to:
The Editorial Office, European Journal of Cancer,
Elsevier Science, The Boulevard,
Langford Lane, Kidlington,
Oxford, OX5 1 GB
United Kingdom
Tel: +44(0) 1865 84 36 20 - Fax: +44(0) 1865 84 39 77
Administrative Editor: Suzanne Peedell:
E-mail: ejcancer@elsevier.com


Last updated 02-03-2011